Joy Melnikow, M.D.

Philosophy of Care
Title:
Specialty:
Center/Program Affiliation:
Address:
4860 Y St., Suite 1600
Sacramento, CA 95817
Phone:
Other Languages:
Education:
San Francisco, California
M.D. 1984
San Francisco State University
San Francisco, California
B.A. 1979
Residency:
Amherst, Massachusetts
1984-1987
Family Practice
Board Certifications:
Professional Memberships:
American Academy of Family Physicians
American Public Health Association
California Academy of Family Physicians
North American Primary Care Research Group
Society for Medical Decision Making
Society of Teachers of Family Medicine
Select Recent Publications:
Melnikow J, McGahan C, Sawaya G, Ehlen T, Coldman A. Cervical intraepithelial neoplasia outcomes after treatment: Long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009 ;101:721-8.
Melnikow J, Birch S, Slee C, McCarthy TJ, Helms LJ, Kuppermann M. Tamoxifen for Breast Cancer Risk Reduction: Impact of Alternative Approaches to Quality-of-Life Adjustment on Cost Effectiveness Analysis. Med Care. 2008;46(9):946-53.
Franks P, Lubetkin EI, Melnikow J. Do personal and societal preferences differ by sociodemographic group? Health Econ. 2007;16:319-25.
Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J. Chemoprevention: Drug Pricing and Mortality -- The Case of Tamoxifen. Cancer 2006; 107:950-58.
Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests. Obstetrics & Gynecology 2006; 107:2:321-328.
Keyser JF, Melnikow J, Kupperman M, Birch S, Kuenneth C, Nuovo J, Azari R, Oto-Kent 0, Rooney M. Recruitment Strategies for Minority Participation: Challenges and Cost Lessons from the POWER Interview study. Ethnicity & Disease 2005; 15:395-406.
Paterniti DA, Melnikow J, Nuovo J, Henderson S, DeGregorio M, Kuppermann M, Nease R. "I'm Going To Die of Something Anyway": Women's Perceptions of Tamoxifen for Breast Cancer Risk Reduction. Ethnicity & Disease 2005; 15:365-372.
Melnikow J, Paterniti 0, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S. Preferences of women evaluating risks of tamoxifen. Cancer 2005; 103: 1996-2005.
Kravitz RL, Melnikow J. Medical adherence research: time for a change in direction? Med Care 2004;42:197-9.

